-- The global clinical microbiology market is projected to reach USD 5.77 Billion by 2021 from USD 3.35 Billion in 2016, growing at a CAGR of 11.5% from 2016 to 2021. Clinical microbiology market growth can be attributed to factors such as technological advancements; rising incidence of infectious diseases and growing outbreak of epidemics; growing healthcare expenditure across the world.
Download Brochure of Clinical Microbiology Market spread across 176 Pages, Profiling 10 Companies and Supported with 74 Tables and 62 Figures is now available at http://www.reportsnreports.com/contacts/requestsample.aspx?name=323763 .
Clinical and molecular microbiology is a branch of microbiology which is concerned with the prevention, diagnosis and treatment of infectious diseases. Clinical microbiologists determine the nature of infectious disease and test the ability of various antibiotics to inhibit or kill the microorganisms. Highly respected for its ability to keep pace with advances in this fast moving field.
Key Target Audience
• Microbiological Testing/Clinical Microbiology product manufacturers
• Healthcare service providers (Including hospitals and diagnostic centers)
• Pharmaceutical product manufacturing companies
• Clinical testing laboratories
• Clinical Research Organizations (CROs)
• Food and beverages manufacturing companies
• Petrochemical and biofuel product manufacturing companies
• Oil & gas producing and distribution companies
• Gas operators, distributors, and regulators
• Environmental monitoring committees
• Environmental monitoring product manufacturing companies
• Research laboratories and academic institutes
• Market research and consulting firms
Leading players in clinical microbiology market include bioMerieux S.A. (France),Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.),Cepheid (U.S.) Abbott Laboratories Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), Alere Inc. (U.S.), Bruker Corporation (U.S.), and Hologic, Inc. (U.S.).
Click Here For More Information on Clinical Microbiology Market at with Top Trends and Company Profiles at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=323763 .
Geographically, clinical microbiology market is classified into four regions— North America, Europe, Asia-Pacific, & Rest of the World. North America and Europe are mature markets for clinical microbiology products. Emerging regions such as Asia-Pacific (including Japan, China, and India, among others) are expected to become new revenue-generating pockets in the market in the next five years.
Clinical Microbiology Market, By Disease Area
1 Introduction
2 Respiratory Diseases
3 Bloodstream Infections
4 Gastrointestinal Diseases
5 Sexually Transmitted Diseases
6 Urinary Tract Infections
7 Periodontal Diseases
The clinical microbiology market report also studies factors (such as drivers, restraints, opportunities, and trends) which affect market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for key players.
Click now for more Details, Queries, Other Information and Discount on this study “Microbiology Testing/Clinical Microbiology Market by Microbiology Application (Pharmaceutical, Clinical, Manufacturing, Energy), Clinical Application (Respiratory Diseases, STD, UTI), Product (instruments, Analyzers, Consumables) - Global Forecasts to 2021” report @ http://www.reportsnreports.com/purchase.aspx?name=323763 .
Product development and commercialization and was the key growth strategy adopted by prominent players to strengthen their global positioning in the clinical microbiology market. Moreover, strategies such as agreements, collaborations, and partnerships, acquisitions, and geographic expansions were also adopted by a significant number of market players to strengthen their product portfolios and expand their distribution networks in the global market during 2012–2015.
Break-up of primary participants was as mentioned below:
• By Company Type – Tier 1–33%, Tier 2–46% and Tier 3–21%
• By Designation – C-level–26%, Director Level–20%, Others–54%
• By Region – North America–33%, Europe–29%, AsiaPacific–24%, RoW–14%
Similarly, reagents product segment is further subsegmented into pathogen-specific kits and general reagents. Pathogen-specific kits segment is expected to grow at higher CAGR during the forecast period. Growth of this segment is attributed to factors such as the flexibility pathogen-specific kits offer to end users to optimize the reaction for better results and increasing patient preference across major countries for early and accurate disease diagnosis.
Contact Info:
Name: Mr. Hrishikesh
Email: Send Email
Organization: ReportsnReports
Address: 2nd Floor, Metropole, Next to Inox Theatre, Bund Garden Road, Pune, Maharashtra, India
Phone: +1 888 391 5441
Website: http://www.reportsnreports.com/reports/323763-microbiology-testing-clinical-microbiology-market-by-product-instrument-analyzer-incubator-kit-microscope-molecular-diagnostics-clinical-application-periodontal-disease-respiratory-diseases-std-uti-by-industry-global-forecast-to-2019.html
Release ID: 378293
Google
RSS